Comments on: AngelList Review: Should You Add Angel Investments to Your Portfolio?

By: M&I - Brian

M&I - Brian — Mon, 11 Dec 2023 02:54:32 +0000

I would tend to agree with you. Too much is left “undisclosed” or “confidential,” which is ridiculous when many of these companies have raised capital at higher valuations in later rounds. I don’t use AngelList much anymore for these and other reasons – it would have been better to allocate the same funds to the NASDAQ and use that as my high-risk/high-reward category.

By: John Ford

John Ford — Tue, 05 Dec 2023 19:54:23 +0000

I’ve made about 20 investments via AngelList and overall, I find the reporting to be much less than adequate once the investment has been made. Both Senti Biosciences (through Noveus Capital Management) and Amprius (via Prithvi Ventures) have gone public with NO notice to me as an investor. Our shares have been mysteriously tied up. Eventually Senti resulted in a 90% loss announced by a deposit in my account.

By: M&I - Brian

M&I - Brian — Wed, 22 Jul 2020 13:12:47 +0000

In reply to Al.

Thanks. Yes, we’ve published stories on this one before:

https://mergersandinquisitions.com/finance-product-management/
https://mergersandinquisitions.com/bitcoin-startup/
https://mergersandinquisitions.com/investment-banking-to-sales-tech-start-up/

By: Al

Al — Sun, 19 Jul 2020 14:05:34 +0000

Hey Brian, great post as usual.

Have you come across any individuals tat pivoted from a finance career into product management/digital space? Would love to read an interview on such topics